HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Ronald M Bukowski Selected Research
Ronald M Bukowski Research Topics
Disease
88
Renal Cell Carcinoma (Grawitz Tumor)
04/2023 - 07/2002
56
Neoplasms (Cancer)
01/2016 - 01/2002
10
Fatigue
04/2023 - 11/2004
10
Neoplasm Metastasis (Metastasis)
11/2010 - 08/2003
8
Disease Progression
01/2011 - 01/2007
7
Diarrhea
04/2023 - 01/2007
6
Carcinoma (Carcinomatosis)
01/2012 - 08/2004
5
Hypertension (High Blood Pressure)
04/2023 - 01/2007
5
Kidney Neoplasms (Kidney Cancer)
10/2010 - 03/2006
4
Melanoma (Melanoma, Malignant)
07/2004 - 07/2002
3
Nausea
01/2012 - 03/2009
3
Exanthema (Rash)
12/2010 - 01/2007
3
Anorexia
04/2009 - 11/2004
3
Neutropenia
01/2007 - 01/2003
2
Hand-Foot Syndrome
04/2023 - 08/2009
2
Prostatic Neoplasms (Prostate Cancer)
01/2020 - 09/2004
2
Vomiting
01/2012 - 04/2009
2
Urogenital Neoplasms
11/2010 - 12/2008
2
Breast Neoplasms (Breast Cancer)
08/2010 - 04/2009
2
Brain Neoplasms (Brain Tumor)
03/2010 - 01/2004
2
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2008 - 05/2006
2
Fever (Fevers)
01/2007 - 11/2004
2
Hypoxia (Hypoxemia)
12/2006 - 10/2006
2
Colorectal Neoplasms (Colorectal Cancer)
12/2004 - 11/2002
2
Hematologic Neoplasms (Hematological Malignancy)
11/2004 - 12/2003
2
Leukemia
09/2003 - 04/2003
2
Multiple Myeloma
07/2003 - 11/2002
1
Mucositis
12/2010
1
Urinary Bladder Neoplasms (Bladder Cancer)
11/2010
1
Neuroendocrine Tumors (Neuroendocrine Tumor)
08/2010
1
Carcinoid Tumor (Carcinoid)
08/2010
1
Gastrointestinal Neoplasms (Gastrointestinal Cancer)
08/2010
Drug/Important Bio-Agent (IBA)
21
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2016 - 11/2005
19
Sunitinib (Sutent)
FDA Link
04/2023 - 06/2006
14
Sorafenib (BAY 43-9006)
FDA Link
02/2012 - 03/2006
9
Bevacizumab (Avastin)
FDA Link
02/2011 - 03/2004
8
Interferon-alpha (Interferon Alfa)
IBA
04/2023 - 03/2004
8
Biomarkers (Surrogate Marker)
IBA
01/2013 - 10/2006
8
Cytokines
IBA
03/2009 - 07/2004
7
Tyrosine Kinase Inhibitors
IBA
01/2012 - 11/2007
7
Interferons
IBA
01/2012 - 03/2003
6
Interleukin-2 (IL2)
IBA
01/2012 - 08/2003
5
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
01/2016 - 11/2007
5
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
02/2012 - 08/2003
5
Angiogenesis Inhibitors
IBA
03/2009 - 03/2004
5
Epitopes
IBA
12/2008 - 09/2002
5
Peptides (Polypeptides)
IBA
12/2008 - 09/2002
4
Proteins (Proteins, Gene)
FDA Link
12/2008 - 03/2003
4
peginterferon alfa-2b (Pegintron)
FDA Link
07/2008 - 07/2002
3
TOR Serine-Threonine Kinases
IBA
01/2016 - 09/2007
3
pazopanib
FDA Link
01/2011 - 01/2010
3
Carbonic Anhydrase IX
IBA
10/2010 - 11/2005
3
Hemoglobins (Hemoglobin)
IBA
12/2009 - 10/2006
3
Calcium
IBA
12/2009 - 09/2003
3
Proteasome Endopeptidase Complex (Proteasome)
IBA
08/2009 - 01/2002
3
ErbB Receptors (EGF Receptor)
IBA
04/2009 - 03/2005
3
Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)
IBA
12/2007 - 06/2006
3
Antigens
IBA
01/2007 - 09/2002
3
Enzymes
IBA
09/2003 - 11/2002
2
temsirolimus
FDA Link
09/2012 - 11/2007
2
Phosphotransferases (Kinase)
IBA
02/2012 - 03/2006
2
Diphosphonates (Bisphosphonates)
IBA
11/2010 - 09/2004
2
Zoledronic Acid (Zometa)
FDA Link
11/2010 - 09/2004
2
Everolimus
FDA Link
08/2010 - 10/2009
2
Bortezomib (Velcade)
FDA Link
08/2009 - 05/2006
2
Interferon alpha-2 (Roferon-A)
FDA Link
03/2009 - 07/2004
2
Axitinib (AG 013736)
IBA
03/2009 - 11/2007
2
Ligands
IBA
12/2008 - 04/2008
2
Alkaline Phosphatase
IBA
10/2008 - 10/2006
2
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
10/2008 - 10/2006
2
Paclitaxel (Taxol)
FDA Link
Generic
05/2008 - 01/2007
2
Cytochromes c (Cytochrome c)
IBA
04/2008 - 04/2003
2
Caspases
IBA
04/2008 - 04/2003
2
Gangliosides
IBA
04/2008 - 04/2003
2
shark cartilage extract
IBA
11/2007 - 08/2003
2
Antineoplastic Agents (Antineoplastics)
IBA
10/2006 - 03/2006
2
Thalidomide (Thalomid)
FDA Link
07/2006 - 03/2004
2
Tyrosine (L-Tyrosine)
FDA Link
03/2006 - 03/2004
2
Epidermal Growth Factor (EGF)
IBA
11/2005 - 03/2004
2
Poisons
IBA
08/2004 - 01/2002
2
Type II DNA Topoisomerases (Topoisomerase II)
IBA
09/2003 - 01/2002
1
Androgen Receptors (Androgen Receptor)
IBA
01/2020
1
Vascular Endothelial Growth Factors
IBA
01/2016
1
GSK 1363089
IBA
01/2013
1
tyrosine receptor (receptor, tyrosine)
IBA
02/2012
1
tandutinib
IBA
02/2012
1
cevipabulin
IBA
02/2012
1
Tubulin
IBA
02/2012
1
Paraffin
IBA
01/2012
1
DNA (Deoxyribonucleic Acid)
IBA
01/2012
1
Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
IBA
01/2012
1
Blood Proteins (Serum Proteins)
IBA
10/2010
1
Tissue Inhibitor of Metalloproteinase-1
IBA
10/2010
Therapy/Procedure
42
Therapeutics
02/2012 - 11/2002
9
Drug Therapy (Chemotherapy)
08/2010 - 11/2002
5
Immunotherapy
01/2016 - 11/2006
5
Nephrectomy
10/2008 - 10/2006
4
Radiotherapy
10/2006 - 01/2004
2
Aftercare (After-Treatment)
12/2010 - 12/2008
1
Castration
01/2020